- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03940508
Engaging Black Youth in Depression and Suicide Prevention Treatment Within Urban Schools
Engaging Black Youth in Depression and Suicide Prevention Treatment Within Urban Schools: A Preliminary Study
Completing evidence-based treatments for depression has been shown to be particularly problematic for Black adolescents. If Black adolescents' depression treatment needs are to be met, the engagement challenges and the factors that lessen the success of treatment in the "real world" must be addressed. The investigators will examine the effectiveness of the Making Connections Intervention (MCI) and investigate key mediators of both engagement and response to treatment for depression. The MCI is a 1-2 session, evidence-based intervention designed to improve engagement, perceived relevance, and treatment satisfaction among depressed, Black adolescents. The study also uses tailored outreach strategies for adolescents and parents by including innovative digital content such as a web page/app along with other digital products.
This study will address an important public health issue: How best to connect Black adolescents with depression to treatment in clinically meaningful ways, and how best to deliver evidence-based treatment to them through school-based services.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Completing evidence-based treatments for depression has been shown to be particularly problematic for Black adolescents. Their rates of participation in treatments for depression are lower due to negative perceptions of services and providers, and their reluctance to acknowledge the presence of symptoms.
If Black adolescents' depression treatment needs are to be met, the engagement challenges and the factors that lessen the success of treatment in the "real world" must be addressed. This research examines the effectiveness of the Making Connections Intervention (MCI) and investigates key mediators of both engagement and response to treatment for depression. The MCI is a 1-2 session, evidence-based intervention designed to improve engagement, perceived relevance, and treatment satisfaction among depressed, Black adolescents. The study also uses tailored outreach strategies for adolescents and parents by including innovative digital content such as a web page/app along with other digital products.
The investigators previously performed a small pilot study that used the MCI as an add-on to the IPT-A, an evidence-based intervention for depression delivered in schools typically over 12 sessions. The results suggested that MCI has a positive impact on many aspects of change associated with treatment engagement and clinical outcomes.
This study will be a randomized controlled trial. It will examine the effectiveness of the MCI in a multi-school trial involving adolescents in grades 6-12 who attend New York City (NYC) Department of Education (DOE) Public Schools. The investigators will randomly assign 60 Black students with depression symptoms to two conditions: MCI+IPT-A vs. IPT-A-alone. The investigators will also do qualitative research, like interviews, before the digital content is created. This will enhance the relevance of the MCI. The main outcomes are adolescent-and caregiver-level engagement and adolescent depression. Suicidal ideation is a secondary outcome. This study will also test related factors, like adolescent helping-seeking behavior and parental knowledge of mental health services, that can account for treatment outcomes and that will allow the MCI to be strengthened in future roll-outs of the intervention in school settings.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10003
- Columbia University
-
New York, New York, United States, 10003
- McSilver Institute for Poverty Policy and Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must identify as Black and/or African American
- Must be enrolled in grades 6-12 (except 12th graders in their last semester)
- Must be able to speak English
- Must have received caregiver consent and have assented to participate
- Must meet depression and global functioning levels indicated by a CES-D score ≥16, a Hamilton Rating Scale of Depression (HRSD) Score ≥ 10, and a Global Assessment Scale for Children (C-GAS) score ≤ 65 at baseline
- Students who are currently on a stable dose of anti-depressant medication, but still meet inclusion criteria, can be enrolled in the study.
Exclusion Criteria:
- Actively suicidal with intent or plan
- Intellectually disabled
- Have a life threatening medical illness
- Have a current primary substance abuse diagnosis in the moderate to severe range, schizophrenia, bipolar disorder, any evidence of psychosis, a primary diagnosis of anorexia
- Currently in active treatment for depression (excluding medication) at baseline assessment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MCI + IPT-A
Participants will receive the Making Connections Intervention (MCI) in addition to IPT-A for depression.
|
The MCI is a one to two session intervention that addresses barriers to mental health treatment and helps adolescents build skills to get the most out of their treatment experience.
It is designed to be delivered by a trained clinician in conjunction with an evidence-based treatment.
IPT-A is a time-limited, manualized treatment for depression focused on maladaptive communication patterns and interpersonal interactions.
Other Names:
|
|
Active Comparator: IPT-A Only
Participants will receive IPT-A for depression.
|
IPT-A is a time-limited, manualized treatment for depression focused on maladaptive communication patterns and interpersonal interactions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Center for Epidemiological Studies-Depression Scale
Time Frame: Baseline
|
A 20-item self-report scale designed to measure depressive symptomatology in the general population.
Scores range from 0 to 60, with higher scores indicating greater depression symptoms.
16 is a common clinical cutoff.
|
Baseline
|
|
Hamilton Rating Scale for Depression
Time Frame: Baseline
|
Determines a patient's level of depression before, during, and after treatment.
Scores range from 0 to 52, with higher scores indicating greater severity of depression.
Scores of 0-7 indicate no depression.
|
Baseline
|
|
Demographic Form
Time Frame: Baseline
|
To measure participants' demographic characteristics
|
Baseline
|
|
Columbia-Suicide Severity Rating Scale
Time Frame: Baseline
|
To assess the severity and lethality of suicidal behaviors and ideations, and can be used to monitor treatment outcomes and establish suicide risk in a variety of research and clinical settings.
"Yes" and "No" categories are used to determine suicide risk, with binary coding where No=0 and Yes=1 for items 1-5.
The higher number indicating more intense ideation.
Total scores of items 1-5 were analyzed, with the lowest score =0 and the highest score=5.
|
Baseline
|
|
Barriers for Adolescents Seeking Health
Time Frame: Baseline
|
Self-report questionnaire that targets barriers to seeking professional psychological help.
Scores range from 37 to 111, with higher scores indicating greater barriers to help seeking behaviors.
|
Baseline
|
|
Child Help-Seeking Scale
Time Frame: Baseline
|
Self-report 28-item questionnaire designed to measure children's and adolescents' willingness to seek help for psychosocial problems from adults in the school setting.
Scores for part one range from 16 to 64 and scores for part two rang from 7 to 28, with higher scores indicating less help- seeking.
|
Baseline
|
|
Attitudes Toward Psychological Help Scale
Time Frame: Baseline
|
This scale assesses psychological factors, including stigma, perceived relevance of treatment, etc., that impact one's perceptions of and attitudes about using formal mental health treatment services.
Scores range from 0-15, with higher scores indicating greater stigma.
|
Baseline
|
|
Stages of Change
Time Frame: Baseline
|
32-item instrument for assessing the readiness for changes in relation to general problems, or problems associated with participation in psychotherapy.
The highest score among each sub-scale indicates which stage of change a person is in.
Thus, sub-scale scores are reported.
Sub-scale scores do not indicate a better or worse outcome; instead, higher scores indicate a readiness to take action to address mental health concerns on each sub-scale.
Pre-contemplation scores range from 5-20, Contemplation scores range from 4-16, Action scores range from 5-20, and Maintenance scores range from 4-16.
|
Baseline
|
|
Barriers to Treatment Participation Scale
Time Frame: Baseline
|
To test whether perceived barriers to treatment influence dropping out and other measures of participation in treatment.
To assess a broad range of barriers evident over the course of treatment, including four thematic areas: stressors and obstacles that compete with treatment, treatment demands and issues, perceived relevance of treatment, and relationship with the therapist.
Higher scores indicating greater barriers to treatment.
Sub-scale scores range from 20 to 100 (Stressors), 10-50 (Demands), and 8-40 (Perceived Relevance of Treatment).
|
Baseline
|
|
Understanding Mood Disorders Questionnaire
Time Frame: Baseline
|
Designed to measure family members' attributions about and knowledge of symptoms, course, and treatment of mood disorders.
Scores range from 9 to 40, with higher scores indicating less understanding of how depression presents and functions.
|
Baseline
|
|
Therapy Survey
Time Frame: Baseline
|
To measure change in expectations about treatment at a children's psychiatric clinic about a week before their first therapy and counseling sessions.
Scores range from 7 to 35, with higher scores indicating misconceptions about the role of therapy.
|
Baseline
|
|
Suicidal Ideation Questionnaire-Junior
Time Frame: Baseline
|
A 15-item self-report measure developed specifically for identifying and assessing current suicidal ideation among young adolescents that requires approximately five to eight minutes to complete.
Scores range from 0 to 90, with a typical clinical cutoff score of 31 indicating further evaluation due to increased risk of suicidal ideation.
|
Baseline
|
|
Global Assessment Scale for Children
Time Frame: Baseline
|
To reflect the lowest level of functioning for a child or adolescent during a specified time period, or on a hypothetical continuum of health-illness.
Higher scores indicate higher functioning, ranging from 1-100.
|
Baseline
|
|
Interpersonal Needs
Time Frame: Baseline
|
A 15-item questionnaire to measure changes in students' social connectedness and social competence.
Total scores ranging from 15-99 are reported with higher scores indicated less social connectedness.
|
Baseline
|
|
Penn Helping Alliance Revised
Time Frame: Week 4
|
This questionnaire collects data from both the therapist and patient to measure the strength of the bond between therapist and patient, called the therapeutic alliance.
Scores range from 6 to 36, with a higher score indicating greater therapeutic alliance.
|
Week 4
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael A Lindsey, PhD, NYU Silver School of Social Work
Publications and helpful links
General Publications
- Gunlicks-Stoessel M, Mufson L, Jekal A, Turner JB. The impact of perceived interpersonal functioning on treatment for adolescent depression: IPT-A versus treatment as usual in school-based health clinics. J Consult Clin Psychol. 2010 Apr;78(2):260-7. doi: 10.1037/a0018935.
- Mufson L, Moreau D, Weissman MM, Wickramaratne P, Martin J, Samoilov A. Modification of interpersonal psychotherapy with depressed adolescents (IPT-A): phase I and II studies. J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):695-705. doi: 10.1097/00004583-199406000-00011.
- Mufson LH, Dorta KP, Olfson M, Weissman MM, Hoagwood K. Effectiveness research: transporting interpersonal psychotherapy for depressed adolescents (IPT-A) from the lab to school-based health clinics. Clin Child Fam Psychol Rev. 2004 Dec;7(4):251-61. doi: 10.1007/s10567-004-6089-6.
- Lindsey MA, Chambers K, Pohle C, Beall P, Lucksted A. Understanding the Behavioral Determinants of Mental Health Service Use by Urban, Under-Resourced Black Youth: Adolescent and Caregiver Perspectives. J Child Fam Stud. 2013 Jan 1;22(1):107-121. doi: 10.1007/s10826-012-9668-z. Epub 2012 Oct 16.
- Lindsey MA, Joe S, Nebbitt V. Family Matters: The Role of Mental Health Stigma and Social Support on Depressive Symptoms and Subsequent Help Seeking Among African American Boys. J Black Psychol. 2010 Nov 1;36(4):458-482. doi: 10.1177/0095798409355796.
- Breland-Noble AM, Bell CC, Burriss A; AAKOMA Project Adult Advisory Board. "Mama just won't accept this": adult perspectives on engaging depressed African American teens in clinical research and treatment. J Clin Psychol Med Settings. 2011 Sep;18(3):225-34. doi: 10.1007/s10880-011-9235-6.
- Lindsey MA, Korr WS, Broitman M, Bone L, Green A, Leaf PJ. Help-seeking behaviors and depression among African American adolescent boys. Soc Work. 2006 Jan;51(1):49-58. doi: 10.1093/sw/51.1.49.
- Lindsey MA, Brown DR, Cunningham M. Boys do(n't) cry: Addressing the unmet mental health needs of African American boys. Am J Orthopsychiatry. 2017;87(4):377-383. doi: 10.1037/ort0000198.
- Ellis ML, Lindsey MA, Barker ED, Boxmeyer CL, Lochman JE. Predictors of engagement in a school-based family preventive intervention for youth experiencing behavioral difficulties. Prev Sci. 2013 Oct;14(5):457-67. doi: 10.1007/s11121-012-0319-9.
- Lindsey MA, Mufson L, Velez-Grau C, Grogan T, Wilson DM, Reliford AO, Gunlicks-Stoessel M, Jaccard J. Engaging Black youth in depression and suicide prevention treatment within urban schools: study protocol for a randomized controlled pilot. Trials. 2024 Feb 9;25(1):112. doi: 10.1186/s13063-024-07947-8.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R34MH119290-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Making Connections Intervention
-
Hopeful AgingBenjamin Rose Institute on AgingNot yet recruiting
-
New York State Psychiatric InstituteTerminatedPsychiatric DiagnosisUnited States
-
Massachusetts General HospitalRecruitingObesity | Depression, Anxiety | Cancer Colorectal | Cancer CervixUnited States
-
Saint Luke's Health SystemWithdrawn
-
University of CalgaryAlzheimer's AssociationRecruitingAlzheimer Disease | Mild Dementia | Moderate DementiaCanada
-
University Hospitals, LeicesterCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
Xavier University of Louisiana.National Institute on Minority Health and Health Disparities (NIMHD); Tulane...CompletedProstate CancerUnited States
-
University of WarwickUniversity of BirminghamCompleted
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA)Enrolling by invitationHIV Infections | Substance Use DisordersUnited States